Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera

ClinicalTrials.gov ID: NCT02410278

Public ClinicalTrials.gov record NCT02410278. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double- Blind, Placebo- Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera® (Dimethyl Fumarate) Delayed Release Capsules

Study identification

NCT ID
NCT02410278
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Biogen
Industry
Enrollment
102 participants

Conditions and interventions

Interventions

  • dimethyl fumarate Drug
  • montelukast Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2015
Primary completion
Feb 15, 2017
Completion
Apr 26, 2017
Last update posted
Mar 30, 2020

2015 – 2017

United States locations

U.S. sites
50
U.S. states
25
U.S. cities
49
Facility City State ZIP Site status
Research Site Jonesboro Arkansas 72401
Research Site Carmichael California 95608
Research Site La Jolla California 92037
Research Site La Mesa California 91942
Research Site Pomona California 91767
Research Site Simi Valley California 93065
Research Site Aurora Colorado 80045
Research Site Colorado Springs Colorado 80907
Research Site Fairfield Connecticut 06824
Research Site Washington D.C. District of Columbia 20057
Research Site Jacksonville Florida 32216
Research Site Naples Florida 34102
Research Site Ormond Beach Florida 32174-3102
Research Site Sunrise Florida 33351
Research Site Rome Georgia 30165-1625
Research Site Smyrna Georgia 30269
Research Site Chicago Illinois 60612
Research Site Flossmoor Illinois 60422
Research Site Indianapolis Indiana 46256
Research Site Louisville Kentucky 40207
Research Site Scarborough Maine 04074
Research Site Farmington Hills Michigan 48334
Research Site Chesterfield Missouri 63017
Research Site Kansas City Missouri 64111
Research Site St Louis Missouri 63104
Research Site Freehold New Jersey 07728
Research Site Amherst New York 14226
Research Site New York New York 10029
Research Site Patchogue New York 11772
Research Site Hendersonville North Carolina 28792
Research Site Raleigh North Carolina 27607-6010
Research Site Sanford North Carolina 27330
Research Site Winston-Salem North Carolina 27103
Research Site Dayton Ohio 45417
Research Site Dayton Ohio 45459
Research Site Uniontown Ohio 44685
Research Site Oklahoma City Oklahoma 73109
Research Site Portland Oregon 97225
Research Site Tualatin Oregon 97062
Research Site Dickson City Pennsylvania 18519
Research Site Greensburg Pennsylvania 15601
Research Site Hershey Pennsylvania 17033
Research Site Wilkes-Barre Pennsylvania 18711
Research Site Nashville Tennessee 37215
Research Site Dallas Texas 75214
Research Site Round Rock Texas 78681
Research Site Alexandria Virginia 22310
Research Site Newport News Virginia 23601
Research Site Seattle Washington 98122
Research Site Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02410278, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 30, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02410278 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →